James F. Casella

15.3k total citations · 2 hit papers
151 papers, 5.6k citations indexed

About

James F. Casella is a scholar working on Genetics, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, James F. Casella has authored 151 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Genetics, 77 papers in Hematology and 48 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in James F. Casella's work include Hemoglobinopathies and Related Disorders (98 papers), Iron Metabolism and Disorders (53 papers) and Bone and Joint Diseases (17 papers). James F. Casella is often cited by papers focused on Hemoglobinopathies and Related Disorders (98 papers), Iron Metabolism and Disorders (53 papers) and Bone and Joint Diseases (17 papers). James F. Casella collaborates with scholars based in United States, United Kingdom and Canada. James F. Casella's co-authors include John J. Strouse, Shin Lin, Michael D. Flanagan, Michael R. DeBaun, Anne K. Duggan, Alain Joffe, Ann Bruner, Jason Brandt, Emily Barron‐Casella and Peter Agre and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

James F. Casella

144 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cytochalasin D inhibits actin polymerization and induces depolymerization of actin filaments formed during platelet shape change

1981 406 citations James F. Casella et al. profile →
Partial deficiency of erythrocyte spectrin in hereditary spherocytosis

1985 178 citations James F. Casella et al. profile →

Peers

Countries citing papers authored by James F. Casella

Since Specialization

Citations

This map shows the geographic impact of James F. Casella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James F. Casella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James F. Casella more than expected).

Fields of papers citing papers by James F. Casella

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James F. Casella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James F. Casella. The network helps show where James F. Casella may publish in the future.

Co-authorship network of co-authors of James F. Casella

This figure shows the co-authorship network connecting the top 25 collaborators of James F. Casella. A scholar is included among the top collaborators of James F. Casella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James F. Casella. James F. Casella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Duration of anticoagulation for venous thromboembolism in pediatric patients: Evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT) trial outcomes at 2 years 2024 ·Journal of Thrombosis and Haemostasis ·Neil A. Goldenberg, Sam Schulman, John M. Kittelson, Thomas C. Abshire, James F. Casella, Rita Dale, Jonathan L. Halperin, (unknown), Craig M. Kessler, Marilyn J. Manco‐Johnson, (unknown), Robert F. Sidonio, Alex C. Spyropoulos, Philippe Gabríel Steg, Marc P. Bonaca, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	0
2	Diagnostic utility of telomere length testing in a hospital-based setting 2018 ·Proceedings of the National Academy of Sciences ·Jonathan K. Alder, Vidya Sagar Hanumanthu, Margaret A. Strong, Amy E. DeZern, Susan E. Stanley, Clifford M. Takemoto, Ludmila Danilova, Carolyn Applegate, Stephen G. Bolton, David W. Mohr, Robert A. Brodsky, James F. Casella, Carol W. Greider, J. Brooks Jackson, Mary Armanios	144
3	Developing a risk-based composite neurologic outcome for a trial of hydroxyurea in young children with sickle cell disease 2018 ·Clinical Trials ·James F. Casella, Robert J. Adams, Donald Brambilla, John J. Strouse, (unknown), Rachel Dlugash, Radhika Avadhani, Krista Vermillion, James Tonascia, Jenifer H. Voeks, Daniel F. Hanley, Richard E. Thompson, Harold P. Lehmann	0
4	Children with sickle cell anemia with normal transcranial Doppler ultrasounds and without silent infarcts have a low incidence of new strokes 2018 ·American Journal of Hematology ·Lori C. Jordan, (unknown), Mark Rodeghier, (unknown), Maria Rosana Ponisio, James F. Casella, Robert C. McKinstry, Michael J. Noetzel, Fenella J. Kirkham, Emily Riehm Meier, Beng Fuh, (unknown), Sharada A. Sarnaik, Suvankar Majumdar, Timothy L. McCavit, Michael R. DeBaun	9
5	Immunologic Effects of Hydroxyurea in Sickle Cell Anemia 2014 ·PEDIATRICS ·Howard M. Lederman, Margaret A. Connolly, Ram Kalpatthi, Russell E. Ware, Winfred C. Wang, Lori Luchtman‐Jones, Myron A. Waclawiw, Jonathan C. Goldsmith, (unknown), James F. Casella	38
6	Development and Validation of the Youth Acute Pain Functional Ability Questionnaire (YAPFAQ) 2014 ·Journal of Pain ·William T. Zempsky, (unknown), James P. Santanelli, Tamara New, Kim Smith‐Whitley, James F. Casella, Tonya M. Palermo	17
7	Developmental Function in Toddlers With Sickle Cell Anemia 2013 ·PEDIATRICS ·F. Daniel Armstrong, T. David Elkin, R. Clark Brown, Penny Glass, Sohail Rana, James F. Casella, Ram Kalpatthi, Steven G. Pavlakis, Zhibao Mi, Winfred C. Wang, (unknown)	40
8	Hydroxyurea Is Associated With Lower Costs of Care of Young Children With Sickle Cell Anemia 2013 ·PEDIATRICS ·Winfred C. Wang, Suzette O. Oyeku, Zhaoyu Luo, Sheree L. Boulet, Scott T. Miller, James F. Casella, (unknown), Bruce Thompson, Scott D. Grosse	60
9	Genome-Wide Meta-Analysis of Systolic Blood Pressure in Children with Sickle Cell Disease 2013 ·PLoS ONE ·Pallav Bhatnagar, Emily Barron‐Casella, Christopher J. Bean, Jacqueline N. Milton, Clinton T. Baldwin, Martin H. Steinberg, Michael R. DeBaun, James F. Casella, Dan E. Arking	17
10	Validation of the Sickle Cell Disease Pain Burden Interview–Youth 2013 ·Journal of Pain ·William T. Zempsky, (unknown), James P. Santanelli, Tonya M. Palermo, Tamara New, Kim Smith‐Whitley, James F. Casella	46
11	Acute Silent Cerebral Ischemic Events in Children With Sickle Cell Anemia 2012 ·JAMA Neurology ·Charles T. Quinn, Robert C. McKinstry, Michael M. Dowling, William S. Ball, Michael A. Kraut, James F. Casella, Nomazulu Dlamini, Rebecca Ichord, Lori C. Jordan, Fenella J. Kirkham, Michael J. Noetzel, E. Steve Roach, John J. Strouse, Janet L. Kwiatkowski, Deborah Hirtz, Michael R. DeBaun	48
12	Genome-wide association study identifies genetic variants influencing F-cell levels in sickle-cell patients 2011 ·Journal of Human Genetics ·Pallav Bhatnagar, Shirley H. Purvis, Emily Barron‐Casella, Michael R. DeBaun, James F. Casella, Dan E. Arking, Jeffrey R. Keefer	67
13	Burden of Influenza-Related Hospitalizations Among Children With Sickle Cell Disease 2010 ·PEDIATRICS ·David G. Bundy, John J. Strouse, James F. Casella, Marlene R. Miller	75
14	MRI abnormalities of the brain in one‐year‐old children with sickle cell anemia 2008 ·Pediatric Blood & Cancer ·Winfred C. Wang, Steven G. Pavlakis, Kathleen J. Helton, Robert C. McKinstry, James F. Casella, Robert J. Adams, Renée C. Rees	65
15	Corticosteroids and increased risk of readmission after acute chest syndrome in children with sickle cell disease 2007 ·Pediatric Blood & Cancer ·John J. Strouse, Clifford M. Takemoto, Jeffrey R. Keefer, Gregory J. Kato, James F. Casella	84
16	Pediatric Patients with Sickle Cell Disease: Use of Complementary and Alternative Therapies 2006 ·The Journal of Alternative and Complementary Medicine ·Erica Sibinga, (unknown), James F. Casella, Anne K. Duggan, Modena Wilson	53
17	Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and β-thalassemia 2003 ·Biology of Blood and Marrow Transplantation ·Robert Iannone, James F. Casella, Ephraim J. Fuchs, Allen Chen, Richard J. Jones, Ann E. Woolfrey, Michael D. Amylon, Keith M. Sullivan, Rainer Storb, Mark C. Walters	209
18	High Viral Load and Mild Liver Injury in Children with Hemophilia Compared with Other Children with Chronic Hepatitis C Virus Infection 1999 ·Journal of Pediatric Gastroenterology and Nutrition ·Aglaia Zellos, David L. Thomas, (unknown), Elizabeth J. Perlman, John K. Boitnott, James F. Casella, Kathleen B. Schwarz	1
19	Randomised study of cognitive effects of iron supplementation in non-anaemic iron-deficient adolescent girls 1996 ·The Lancet ·Ann Bruner, Alain Joffe, Anne K. Duggan, James F. Casella, Jason Brandt	476
20	The capactins, a class of proteins that cap the ends of actin filaments 1982 ·Philosophical transactions of the Royal Society of London. Series B, Biological sciences ·S. Lin, David H. Cribbs, James A. Wilkins, James F. Casella, (unknown), Dana Lin	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact